Evidence map›Paper›PMID 35606628›Full record

ReviewTopics in current chemistry (Cham)2022

Methods for Direct Reductive N-Methylation of Nitro Compounds.

Zhijie Jiang, Evan Abdulkareem Mahmood, Nazanin Zare Harofteh, Abdol Ghaffar Ebadi, Mohsen Toughani, Esmail Vessally

Abstract readReview
PubMed Publisher
In one paragraph

Review in Topics in current chemistry (Cham), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 4 countries.

Zhijie JiangSchool of Chemistry and Chemical Engineering, Shaanxi Xueqian Normal University, Xi'an, 710100, China. 25035@snsy.edu.cn.
Evan Abdulkareem MahmoodMedical Laboratory Sciences Department, College of Health Sciences, University of Human Development, Sulaymaniyah, Iraq.
Nazanin Zare HaroftehGeneral Medicine Department, Faculty of Medicine, Saint Petersburg State University, Saint Petersburg, Russia.
Abdol Ghaffar EbadiDepartment of Agriculture, Jouybar Branch, Islamic Azad University, Jouybar, Iran.
Mohsen ToughaniDepartment of Fishery, Babol Branch, Islamic Azad University, Babol, Iran.
Esmail VessallyDepartment of Chemistry, Payame Noor University, P.O. Box 19395-4697, Tehran, Iran. vessally@yahoo.com.
Islamic Azad University, BabolIslamic Azad University, Tehran · IRPayame Noor University · IRShaanxi Xueqian Normal University · CNSt Petersburg University · RUUniversity of Human Development · IQ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Direct reductive N-methylation of inexpensive and readily available nitro compounds as raw material feedstocks is more attractive and straightforward compared with conventional N-methylation of amines to prepare biologically and pharmaceutically important N-methylated amine derivatives. This strategy for synthesis of N-methylamines avoids prepreparation of NH-free amines and therefore significantly shortens the separation and purification steps. In recent years, numerous methylating agents and catalytic systems have been reported for this appealing transformation. Thus, it is an appropriate time to summarize such advances. This review elaborates on the most important discoveries and advances in this research arena, with special emphasis on the mechanistic aspect of reactions that may provide new insights into catalyst improvement.

Indexed as

AminesNitro CompoundsCatalysisMethylationAminesNitro CompoundsFormaldehydeMethanolNitro compoundsN-MethylaminesN-MethylationReduction

Identifiers

PMID35606628
OpenAlexW4281393732

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.